Jasper Therapeutics

-$0.01 (-0.52%) As of 3:58 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JSPR and other ETFs, options, and stocks.

About JSPR

Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation.

CEO
Ronald A. Martell
Employees
25
Headquarters
Redwood City, California
Founded
2018

JSPR Key Statistics

Market cap
72.72M
Price-Earnings ratio
—
Dividend yield
—
Average volume
46.59K
High today
$1.92
Low today
$1.91
Open price
$1.91
Volume
6.96K
52 Week high
$18.88
52 Week low
$1.73

JSPR Earnings

-$0.69
-$0.46
-$0.23
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 12, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure